Clinical Trials Directory

Trials / Completed

CompletedNCT00469573

Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Innovative Medical · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if Optive®eye drops are safe for people who wear contact lenses and have dry eyes. The second goal of the study is to determine if using Optive®eye drops can improve my dry eye scores on a standard dry eye test (called the OSDI).

Conditions

Interventions

TypeNameDescription
DRUG1. OptiveOptive 15ml- (in the eye) Instill one drop twice daily in each eye

Timeline

Start date
2007-05-01
Primary completion
2008-03-01
Completion
2008-03-01
First posted
2007-05-04
Last updated
2008-04-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00469573. Inclusion in this directory is not an endorsement.